Article Information
History
- June 12, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Stuart A Rushwortha,*,
- Benjamin B Johnsona,
- Karen Ashurstb,
- Rose Davidsona,c,
- Paige Paddyc,
- Jayna J Mistrya,
- Jamie A Moorea,
- Charlotte Hellmicha,d,
- Dylan R Edwardsa,
- Daniela Da Luz Afonsoe,
- Georgios Xydopoulose,
- Richard Goodwinf,
- Javier Gomezb,
- Reenesh Prakashb,
- Samir Dervisevicb,
- Richard Fordhame,*,
- Kristian M Bowlesa,b,d,f,* and
- James G W Smitha,*
- aNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
- bMicrobiology Department, Norfolk and Norwich University Hospitals NHS Trust, Colney Lane, Norwich, NR4 7UY, United Kingdom
- CSchool of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
- dDepartment of Haematology, Norfolk and Norwich University Hospitals NHS Trust, Colney Lane, Norwich, NR4 7UY, United Kingdom
- eHealth Economics Consulting, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
- fCOVID-19 Incident Management Team, Norfolk and Norwich University Hospitals NHS Trust, Colney Lane, Norwich, NR4 7UY, United Kingdom
- ↵*Denotes joint corresponding author, Corresponding authors: Dr James Smith, Prof Kristian Bowles and Dr Stuart Rushworth, Norwich Medical School, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom. email: J.G.Smith{at}uea.ac.uk, s.rushworth{at}uea.ac.uk, r.fordham{at}uea.ac.uk or k.bowles{at}uea.ac.uk
Posted June 12, 2020.
Performance and health economic evaluation of the Mount Sinai COVID-19 serological assay identifies modification of thresholding as necessary to maximise specificity of the assay
